During their long co-evolution, bacteria and their animal host have developed mutualistic interactions that are regulated by the immune system of the host. A dialogue between bacteria and the host immune system is initiated at birth during microbial colonization. This colonization induces the recruitment of multiple immune cell types that cooperate with the intestinal epithelium to construct a barrier capable of confining the microbes within the intestinal lumen. Regulatory mechanisms avoid deleterious inflammatory reactions that would harm both the host and its microbiota. In mouse, homeostatic activation of the intestinal immune system is recapitulated by a small number of bacteria, and more particularly by the segmented filamentous bacteria.
Strengths
The review progresses coherently from the physical epithelial barrier through innate immune cells and innate lymphoid cells to adaptive T-cell and IgA responses, with each section advancing a clear reasoning chain from colonization to barrier construction to homeostatic regulation.
↳ Main text sections; Figure 1
Throughout, the review distinguishes established murine findings from uncertain human relevance, and the conclusion explicitly states that the type bacterium SFB remains to be formally demonstrated in humans.
↳ Conclusion p.967; hedging language throughout
The review marshals 42 references spanning foundational and contemporaneous primary research, including landmark SFB and Treg-induction studies, supporting key claims with specific citations to high-impact sources.
↳ Reference list; refs 22-23, 27-28
Limitations
The entire mechanistic framework rests on gnotobiotic mouse studies, yet the translational limitations of this model are confined to a brief conclusion rather than developed in depth.
↳ Limitation confined to conclusion p.967
The review updates and contextualizes the conceptual framework established in the authors' prior syntheses rather than advancing a new framework, limiting its standing as an original contribution.
↳ Sections relative to ref 18 (Nat Rev Immunol 2010)
Findings sit at the mechanism-characterized-under-controlled-conditions stage with no implementation guidance, and the SFB-specific results carry uncertain human relevance, constraining near-term translational and cross-species transfer.
↳ SFB sections; conclusion p.967
The review's clear, logically ordered structure and calibrated hedging of mouse-versus-human claims anchored its strong Reporting and solid Methodological Rigour assessments. Its Contribution and Positioning scores reflect a synthesis that competently integrates and situates the literature but updates rather than advances the framework and treats the limitations of the underpinning gnotobiotic mouse model only briefly. Impact potential was held to a moderate level by the heavily mouse-based evidence and the explicit acknowledgment that the central SFB findings remain unproven in humans, with no implementation pathway articulated. The chief site of evaluative divergence was how much weight to place on the located gnotobiotic-model gap relative to the genuine quality of the integrative synthesis, which was resolved toward a solid-but-incremental reading.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Sound3.5
Confidence highThe review's value is integrative rather than conceptually novel, organizing a broad mechanistic literature (epithelium, ILC3, dendritic cells, T-cell polarization, IgA, SFB) into a coherent developmental narrative. It updates rather than advances the framework established in the authors' prior synthesis, with claims kept proportionate to the evidence.
son existence chez l'homme reste a demontrer formellement
The argument is logically ordered from physical barrier through innate to adaptive immunity and culminates in the SFB case, supported by a curated set of high-impact primary references and effective synthesizing figures. Identifiable weaknesses include an author-centric SFB focus and limited engagement with the limitations of the gnotobiotic model.
The French prose is precise and logically structured, with technical terms defined in footnotes and a bilingual abstract that accurately reflects the body. Qualifying language consistently distinguishes established mouse findings from uncertain human relevance.
The review engages substantively with the 2007-2016 microbiota-immunity literature and cites the principal mechanistic studies, but the translational limitations of the gnotobiotic mouse model underpinning the entire framework are confined to a brief conclusion. The contemporaneous debate over SFB's human relevance is acknowledged but not developed.
No concerns4 of 4 checks
The review is internally consistent: the abstract and English summary accurately reflect the body, figure legends match the textual mechanistic descriptions, and the conclusion appropriately hedges the human relevance of SFB. No statistical, methods-results, or selective-reporting checks apply to a narrative review with no original data.
No original empirical data, human/animal study conduct, ethics approval, or data/code claims require auditing in this narrative review. A conflict-of-interest declaration is present in the end matter. A self-citation pattern toward the authors' own prior work is present but expected for a specialist review and not a misconduct signal.
All 42 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
References not verified automatically are resolved manually within 24 hours.
No retraction or expression of concern found in Crossref (includes Retraction Watch).
Sources: Crossref (incl. Retraction Watch) ✓
Where this paper’s evidence sits on the path from initial observation to real-world use.
The synthesized findings sit at the mechanism-characterized-under-controlled-conditions stage (gnotobiotic mouse models) with no implementation guidance or clinical translation pathway. The central SFB findings are explicitly undemonstrated in humans.
son existence chez l'homme reste a demontrer formellement
AI-generated, human-governed. Something look off? Contact us to request a review.
Keep reading
Other papers Nabu has evaluated blind, starting with the same field.
Iveland, Hagen, Sharma, et al. · 2020 · Basic medicine
UNG2 degradation appeared to be ubiquitous and was observed across several mammalian cell lines of different origin and with several HDACis.
SupportedKavli, Iveland, Buchinger, et al. · 2021 · Biological sciences
we demonstrate that uracil-DNA glycosylase (UNG), but not SMUG1 efficiently excises uracil from replication protein A (RPA)-coated ssDNA
SupportedIveland, Hagen, de Sousa, et al. · 2025 · Basic medicine
MS275 enhanced the sensitivity of A549 cells to pemetrexed, but only when administered following prior treatment with pemetrexed.
Supported